Risk factors and survival prediction model establishment for prognosis in patients with radical resection of gallbladder cancer

Table 1 Clinical characteristics of patients undergoing curative surgery for gallbladder cancer (n = 93), n (%)

Factor	n = 93
Age (mean ± SD)	64.18 ± 12.05
Age distribution
< 40	2 (2.15)
40-49	9 (9.68)
50-59	23 (24.73)
60-69	21 (22.58)
70-80	32 (34.41)
> 80	6 (6.45)
Sex
Male	38 (40.86)
Female	55 (59.14)
Gallstones
Yes	42 (45.16)
No	51 (54.84)
Hematologic parameters
Red blood cell (1012/L)	4.15 ± 1.82
White blood cell (109/L)	7.60 ± 3.27
Hemoglobin (g/L)	122.62 ± 16.83
Neutrophils (%)	41.04 ± 12.91
Lymphocytes (%)	18.99 ± 10.91
Liver function test
ALT (U/L)	43.71 ± 35.03
AST (U/L)	43.13 ± 40.61
ALP (U/L)	89.15 ± 74.44
ALP (U/L)	71.99 ± 82.92
GGT (U/L)	35.94 ± 6.19
Albumin (g/L)	43.71 ± 35.03
Bilirubin Level
TB (umol/L)	33.84 ± 56.43
DB (umol/L)	6.01 ± 3.62
CA19-9 marker
Positive	41 (44.09)
Negative	52 (55.91)
Adjuvant therapy
Yes	44 (47.31)
No	49 (52.69)

ALT: Alanine Aminotransferase; AST: Aspartate Aminotransferase; ALP: Alkaline Phosphatase; GGT: Gamma-Glutamyl Transferase; TB: Total Bilirubin; DB: Direct Bilirubin; CA19-9: Carbohydrate antigen 19-9.